Related references
Note: Only part of the references are listed.IL-36 Promotes Myeloid Cell Infiltration, Activation, and Inflammatory Activity in Skin
Alexander M. Foster et al.
JOURNAL OF IMMUNOLOGY (2014)
Blockade of IL-36 Receptor Signaling Does Not Prevent from TNF-Induced Arthritis
Anja Derer et al.
PLOS ONE (2014)
The novel cytokine interleukin-36α is expressed in psoriatic and rheumatoid arthritis synovium
Silke Frey et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
The severity of experimental arthritis is independent of IL-36 receptor signaling
Celine Lamacchia et al.
ARTHRITIS RESEARCH & THERAPY (2013)
IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells
Solenne Vigne et al.
BLOOD (2012)
Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk
Luigi Tortola et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
IL-36R ligands are potent regulators of dendritic and T cells
Solenne Vigne et al.
BLOOD (2011)
Interleukin-36-Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
Slaheddine Marrakchi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes
David Magne et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Share Paper
